In the context of cancer, pDCs possess proinflammatory activity (IFN I production and antigen presentation) as well as pro-tumorigenic activity (secretion of IL10, TGFb, and checkpoint ligands suppressing CD8+ T cell activity) [94,95]. This evidence concerns the gene CD8A and cancer.